However, CD11b+ DCs and CD103+ DCs from Il9r−/− tumor bearing mice demonstrated decreased pSTAT3 and increased expression of several markers that associated with anti-tumor immunity (Supplementary Fig. 5e, f). The gene discussed is ITGAM; the disease is neoplasm.